Visual Impairment News and Research

Latest Visual Impairment News and Research

Gene editing could be used to halt kidney disease in patients with Joubert syndrome

For the first time scientists have identified how to halt kidney disease in a life-limiting genetic condition, which may pave the way for personalized treatment in the future.

16 Nov 2018

Increasing omega-3 fatty acid intake during pregnancy reduces risk of premature birth, review finds

A new Cochrane Review published today has found that increasing the intake of omega-3 long-chain polyunsaturated fatty acids during pregnancy reduces the risk of premature births.

15 Nov 2018

Calcified nodules in the retina increase risk for progression to late stages of AMD

Calcified nodules in the retina are associated with progression to late stages of age-related macular degeneration.

14 Nov 2018

Researchers to develop sports-specific classification system for blind football

The University of Chichester has been chosen to lead research into a developing a sports-specific classification system for blind football.

13 Nov 2018

Computer games and a summer birthday linked to increased risk of myopia in childhood

According to a new study by researchers in King's School of Life Course Sciences, time spent playing computer games and being born in the summer are both linked to an increased risk of developing short or near sightedness (myopia) in childhood.

8 Nov 2018

Maternal smoking during pregnancy associated with increased risk of strabismus in offspring

In an Acta Ophthalmologica analysis of 11 relevant articles, maternal smoking during pregnancy was associated with a 46 percent increased risk that offspring will develop strabismus—one of the most prevalent eye-related diseases among children.

7 Nov 2018

FDA approves LORBRENA for treatment of patients with ALK-positive metastatic NSCLC

Pfizer Inc. today announced that the U.S. Food and Drug Administration has approved LORBRENA, a third-generation anaplastic lymphoma kinase tyrosine kinase inhibitor for patients with ALK-positive metastatic non-small cell lung cancer whose disease has progressed on crizotinib and at least one other ALK inhibitor for metastatic disease; or whose disease has progressed on alectinib or ceritinib as the first ALK inhibitor therapy for metastatic disease.

5 Nov 2018

Researchers find a class of drug that could be promising treatment for uveitis

Ocular inflammation uveitis is a serious disease that can destroy eye tissue and cause irreversible blindness.

2 Nov 2018

Premature babies with low levels of blood platelets have increased risk of blindness

Premature babies with low levels of platelets (thrombocytes) in their blood run a greatly increased risk of being afflicted with a severe variation of retinopathy of prematurity, an eye disease that can cause blindness, according to a study from Sweden and US published in the journal JCI Insight.

11 Oct 2018

Molecular pathways underlying myopia open new ways for drug development

Myopia (nearsightedness) and hyperopia (farsightedness) develop through different molecular pathways, according to a new study publishing October 9 in the open-access journal PLOS Biology by Andrei Tkatchenko of Columbia University and colleagues.

10 Oct 2018

Pfizer announces FDA approval of VIZIMPRO for first-line treatment of EGFR-mutated metastatic NSCLC

Pfizer Inc. today announced that the U.S. Food and Drug Administration has approved VIZIMPRO [vih-ZIM-pro] (dacomitinib), a kinase inhibitor for the first-line treatment of patients with metastatic non-small cell lung cancer with epidermal growth factor receptor exon 19 deletion or exon 21 L858R substitution mutations as detected by an FDA-approved test.

28 Sep 2018

Novartis announces winners of 2018 eXcellence in Ophthalmology Vision Award

Novartis announced the winners of the 2018 eXcellence in Ophthalmology Vision Award for nonprofit eye health initiatives at EURETINA 2018.

25 Sep 2018

Multi-year study data shows impact of new soft contact lens to slow myopia progression in children

New four-year study data shows the significant impact of a pioneering contact lens management approach to slowing the progression of myopia (nearsightedness) in children, including those whose treatment begins later.

19 Sep 2018

Study shows steep inequality in usage of low vision devices

Blacks and Hispanics who have trouble seeing are missing out on the low vision technology that can help them read, drive and keep up social connections.

7 Sep 2018

Novel tests to better assess earlier stages of AMD

The European MACUSTAR consortium is conducting a multi-country clinical study on age-related macular degeneration coordinated by the University of Bonn.

29 Aug 2018

UK’s leading sight loss charity invites applications from brightest minds in ophthalmic research

Fight for Sight, the UK’s leading sight loss charity, has announced that the Project Grants Awards and the recently established Primer Fellowship call is now open for applications.

17 Aug 2018

Study examines how a person adapts to visual field loss after stroke

A new University of Liverpool study, published in Wiley Brain and Behaviour, examines the factors that influence how a person adapts to visual field loss following stroke.

13 Aug 2018

Saving sight of millions by making eye injections safe and comfortable

Two eye surgeons have written a first-of-its-kind book to save the sight of millions of patients around the world by making eye injections safe and comfortable.

7 Aug 2018

EMA grants orphan designation to selumetinib for treatment of neurofibromatosis type 1

AstraZeneca and Merck, known as MSD outside the U.S. and Canada, today announced that the European Medicines Agency (EMA) has granted orphan designation to selumetinib, a MEK 1/2 inhibitor, for the treatment of neurofibromatosis type 1 (NF1).

3 Aug 2018

Even after lobectomy a child's brain rewires to compensate for the lost parts

An amazing new case study reports on an 11-year-old boy, code named UD (to protect his privacy), who underwent a procedure to remove a part of his brain that resulted in the rewiring of the rest of it over time.

1 Aug 2018

Visual Impairment News and Research

Latest Visual Impairment News and Research

Gene editing could be used to halt kidney disease in patients with Joubert syndrome

Increasing omega-3 fatty acid intake during pregnancy reduces risk of premature birth, review finds

Calcified nodules in the retina increase risk for progression to late stages of AMD

Researchers to develop sports-specific classification system for blind football

Computer games and a summer birthday linked to increased risk of myopia in childhood

Maternal smoking during pregnancy associated with increased risk of strabismus in offspring

FDA approves LORBRENA for treatment of patients with ALK-positive metastatic NSCLC

Researchers find a class of drug that could be promising treatment for uveitis

Premature babies with low levels of blood platelets have increased risk of blindness

Molecular pathways underlying myopia open new ways for drug development

Pfizer announces FDA approval of VIZIMPRO for first-line treatment of EGFR-mutated metastatic NSCLC

Novartis announces winners of 2018 eXcellence in Ophthalmology Vision Award

Multi-year study data shows impact of new soft contact lens to slow myopia progression in children

Study shows steep inequality in usage of low vision devices

Novel tests to better assess earlier stages of AMD

UK’s leading sight loss charity invites applications from brightest minds in ophthalmic research

Study examines how a person adapts to visual field loss after stroke

Saving sight of millions by making eye injections safe and comfortable

EMA grants orphan designation to selumetinib for treatment of neurofibromatosis type 1

Even after lobectomy a child's brain rewires to compensate for the lost parts

Small solutions for big problems in drug discovery and delivery

Professor Nancy Ip: Pioneering New Paths in Neurodegenerative Therapy

Utilizing process Raman in optimizing cultivated meat production

Visual Impairment News and Research

Latest Visual Impairment News and Research

Small solutions for big problems in drug discovery and delivery

Professor Nancy Ip: Pioneering New Paths in Neurodegenerative Therapy

Utilizing process Raman in optimizing cultivated meat production

Newsletters you may be interested in